Lantanon (Mianserin Hydrochloride)

Mianserin hydrochloride blocks central α2‑adrenergic receptors and selectively antagonizes serotonin 5‑HT2 and 5‑HT3 receptors. This action increases the release of norepinephrine and serotonin, enhancing neurotransmission in brain pathways that are typically under‑active in depression, thereby improving mood and related symptoms.

The appropriate dose of Lantanon is determined individually by a qualified prescriber based on the patient’s clinical condition, response, and tolerability. Dosage adjustments may be made during treatment, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for mianserin hydrochloride during pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Consequently, the drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and it is generally avoided unless specifically advised by a physician.

To request Lantanon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with selective serotonin reuptake inhibitors (SSRIs), mianserin has a broader receptor profile, affecting both norepinephrine and serotonin pathways and often causing more sedation and weight gain. It may be chosen when patients do not respond adequately to SSRIs or when a sedating effect is clinically desirable.

Lantanon tablets should be stored at ambient temperature, preferably below 25 °C. Keep the medication in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Lantanon is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets should be swallowed whole with a glass of water and not chewed or crushed, unless the prescriber provides specific instructions for an alternative method of administration.

Serious adverse reactions associated with Lantanon include agranulocytosis, seizures, cardiac arrhythmias such as QT prolongation, severe hypotension, and the emergence or worsening of suicidal thoughts, especially during the early weeks of therapy. Patients should seek immediate medical attention if any of these events occur.

Lantanon is contraindicated in individuals who are currently taking monoamine oxidase inhibitors, have a known hypersensitivity to mianserin or any excipients, or have a history of severe cardiac conduction disorders. Caution is also advised for patients with uncontrolled hypertension, severe liver disease, or those at high risk for suicidal behavior.